Sustained organic growth and strong margin increase
28 oktober, 14:00
28 oktober, 14:00
Third quarter of 2025 in brief
Business area performance
Medical Solutions sales amounted to SEK 1,311 million (1,355); adjusted for currency, this was an increase of 2%. Operating profit (EBITA) increased to SEK 159 million (145), and EBITA margin rose to 12.1% (10.7). The business area continues to invest in future growth by expanding capacity in Hungary and Poland as well as by establishing operations in Malaysia. The latter strengthens capabilities for further growth in Asia, as well as global production flexibility. The previously communicated customer project in Hungary is running according to plan and validation deliveries have begun. It is estimated that these deliveries will be at around the same levels in the coming quarters and then subsequently increase.
Engineered Solutions sales amounted to SEK 1,035 million (1,046); adjusted for currency, this was an increase of 2%. Operating profit (EBITA) was SEK 120 million (103) and EBITA margin rose to 11.6% (9.8). Sales to the automotive industry increased through higher project invoicing and an upbeat performance for the Hygiene market area, while at the same time previous initiatives in consumer electronics in Asia are yielding results. Implemented cost adjustments, heightened capacity utilization and advanced market positions contributed to the strong margin growth.
Materials saw lower volumes in the quarter in the Automotive segment, resulting in slightly negative growth.
First nine months of 2025 in brief
Comments from the CEO
Christer Wahlquist, President and CEO of Nolato AB, commented:
It is gratifying to see that both our business areas continue to grow organically despite a persistently challenging operating environment. At the same time, EBITA margin rose by a full 2.2 percentage points to 12.0% from the comparative quarter, which means that we are already in line with the financial target presented at our Capital Markets Day in March.
Cash flow after investments was slightly lower than last year; note, however, that we are continuing our significant planned investments. Net financial liabilities in relation to operating profit (EBITDA) amounted to 0.6x, thus remaining low. Our acquisition strategy has, in the past, focused on extending our geographical reach to ensure that we can meet our customers’ needs on all continents – a position we have now established. Going forward, focus will shift to complementing our existing business with expertise in new materials and technologies.
Overall, we will continue on Nolato’s strategic journey with increased profitable growth in focus, based on our global capabilities that enable directing business and production to the regions that best meet customers’ needs. Besides, we have a strong financial position that gives us flexibility and enables investing both in new customer projects and bolt-on acquisitions.
Contact
For further information, please contact:
Christer Wahlquist, President and CEO, +46 (0)705 804848
Per-Ola Holmström, CFO, +46 (0)705 763340, per-ola.holmstrom@nolato.com
About Us
Nolato is a Swedish group with operations in Europe, Asia, and North America. We develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading customers within medical technology, pharmaceuticals, consumer electronics, telecom, automotive, hygiene and other selected industrial sectors. Nolato’s shares are listed on Nasdaq Stockholm in the Large Cap segment, where they are included in the Industrials sector. www.nolato.com/IR
This information is information that Nolato is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-10-28 14:00 CET.
Attachments
28 oktober, 14:00
Third quarter of 2025 in brief
Business area performance
Medical Solutions sales amounted to SEK 1,311 million (1,355); adjusted for currency, this was an increase of 2%. Operating profit (EBITA) increased to SEK 159 million (145), and EBITA margin rose to 12.1% (10.7). The business area continues to invest in future growth by expanding capacity in Hungary and Poland as well as by establishing operations in Malaysia. The latter strengthens capabilities for further growth in Asia, as well as global production flexibility. The previously communicated customer project in Hungary is running according to plan and validation deliveries have begun. It is estimated that these deliveries will be at around the same levels in the coming quarters and then subsequently increase.
Engineered Solutions sales amounted to SEK 1,035 million (1,046); adjusted for currency, this was an increase of 2%. Operating profit (EBITA) was SEK 120 million (103) and EBITA margin rose to 11.6% (9.8). Sales to the automotive industry increased through higher project invoicing and an upbeat performance for the Hygiene market area, while at the same time previous initiatives in consumer electronics in Asia are yielding results. Implemented cost adjustments, heightened capacity utilization and advanced market positions contributed to the strong margin growth.
Materials saw lower volumes in the quarter in the Automotive segment, resulting in slightly negative growth.
First nine months of 2025 in brief
Comments from the CEO
Christer Wahlquist, President and CEO of Nolato AB, commented:
It is gratifying to see that both our business areas continue to grow organically despite a persistently challenging operating environment. At the same time, EBITA margin rose by a full 2.2 percentage points to 12.0% from the comparative quarter, which means that we are already in line with the financial target presented at our Capital Markets Day in March.
Cash flow after investments was slightly lower than last year; note, however, that we are continuing our significant planned investments. Net financial liabilities in relation to operating profit (EBITDA) amounted to 0.6x, thus remaining low. Our acquisition strategy has, in the past, focused on extending our geographical reach to ensure that we can meet our customers’ needs on all continents – a position we have now established. Going forward, focus will shift to complementing our existing business with expertise in new materials and technologies.
Overall, we will continue on Nolato’s strategic journey with increased profitable growth in focus, based on our global capabilities that enable directing business and production to the regions that best meet customers’ needs. Besides, we have a strong financial position that gives us flexibility and enables investing both in new customer projects and bolt-on acquisitions.
Contact
For further information, please contact:
Christer Wahlquist, President and CEO, +46 (0)705 804848
Per-Ola Holmström, CFO, +46 (0)705 763340, per-ola.holmstrom@nolato.com
About Us
Nolato is a Swedish group with operations in Europe, Asia, and North America. We develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading customers within medical technology, pharmaceuticals, consumer electronics, telecom, automotive, hygiene and other selected industrial sectors. Nolato’s shares are listed on Nasdaq Stockholm in the Large Cap segment, where they are included in the Industrials sector. www.nolato.com/IR
This information is information that Nolato is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-10-28 14:00 CET.
Attachments
Investmentbolagen
Rapportsäsongen
AI-bolagen
Analys

Placera i Schweiz

Svensk ekonomi
Investmentbolagen
Rapportsäsongen
AI-bolagen
Analys
Placera i Schweiz

Svensk ekonomi
1 DAG %
Senast

Lifco
7 november, 18:28
Lifcos VD köper aktier
Mowi
7 november, 18:01
Över en miljon laxar döda på Mowis anläggning
Investor A
7 november, 17:41
Sur avslutning på börsveckan – Raysearch rapportrusade
OMX Stockholm 30
1 DAG %
Senast
2 733,11